Arthritis drug Bextra found to promote heart attacks and strokes

Email this article to a friend

Printable Version

Articles Related to This Article: • Arthritis drug researchers apologize for undisclosed pharmaceutical industry ties • FDA whistleblower warns about safety of new arthritis drug Arcoxia • Rheumatoid Arthritis Drug Linked to Serious Infections and Cancers (press release) NaturalNews Store Specials: • Raw organic Vanilla powder at 40% off • SunWarrior Ormus Greens at 20% off (3-pack) • Revolutionary new Hurom Slow Juicer at the lowest price on the 'net + FREE shipping! • Certified Organic Nutiva Hemp Seeds at a huge discount (+ FREE bottle of hemp oil) See more at the NN store...

Following the recent revelations that Vioxx cause a high incidence of heart attacks and strokes, a competing drug from Pfizer, Bextra, has now been shown to display similar health problems. What's especially weighty about this particular revelation is that it comes from the American Heart Association, a disease-industry group that has traditionally acted in favor of pharmaceutical companies. Because of this, the AHA deserves credit for allowing this study to be published.

In the preliminary results, Bextra was found to increase the incidence of heart attacks and strokes by 219%. The cardiologist who presented the study, Dr. Garret Fitzgerald, called Bextra, "A time bomb waiting to go off," and noted that the apparent dangers of Bextra exceed those associated with Vioxx.

Pfizer, of course, downplayed the study in an attempt to minimize any negative backlash from its release. The question remains, however: will Pfizer now follow in Merck's footsteps and voluntarily recall Bextra? And if it refuses to do so, will the FDA step in and finally perform the regulatory function it has been so reluctant to use by banning Bextra from the market? Or will this warning be swept aside in favor of a policy that allows this drug to continue to be sold to tens of millions of Americans, regardless of its questionable safety?

Share

About the author: Mike Adams is a consumer health advocate with a passion for sharing empowering information to help improve personal and planetary health He has authored more than 1,500 articles and dozens of reports, guides and interviews on natural health topics, reaching millions of readers with information that is saving lives and improving personal health around the world. Adams is an honest, independent journalist and accepts no money or commissions on the third-party products he writes about or the companies he promotes. In 2007, Adams launched EcoLEDs, a maker of energy efficient LED lights that greatly reduce CO2 emissions. He's also a veteran of the software technology industry, having founded a personalized mass email software product used to deliver email newsletters to subscribers. Adams is currently the executive director of the Consumer Wellness Center, a 501(c)3 non-profit, and regularly pursues cycling, nature photography, Capoeira and Pilates. Known on the 'net as 'the Health Ranger,' Adams shares his ethics, mission statements and personal health statistics at www.HealthRanger.org


Get articles like this delivered to you FREE in our popular email newsletter

Related CounterThink Cartoons:

Related Articles: • Arthritis drug researchers apologize for undisclosed pharmaceutical industry ties • FDA whistleblower warns about safety of new arthritis drug Arcoxia • Rheumatoid Arthritis Drug Linked to Serious Infections and Cancers (press release)	Take Action: Support NaturalNews.com Email this article to a friend Share this article on: NewsVine | digg | del.icio.us Permalink to this article: http://www.NaturalNews.com/002348_arthritis_drug_Bextra_Pfizer.html Reprinting this article: Non-commercial use OK, cite NaturalNews.com with clickable link. Embed article link: (copy HTML code below): <a href = "http://www.NaturalNews.com/002348_arthritis_drug_Bextra_Pfizer.html">Arthritis drug Bextra found to promote heart attacks and strokes</a>